Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Thrombopoietin (TPO)]

Akaru Ishida1, Makoto Handa

  • 1Department of Transfusion Medicine and Cell Therapy, Faculty of Medicine, Keio University.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|September 10, 2005
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

β-Diketonate-bearing half-paddlewheel-type diruthenium(II,II) naphthyridine complexes with well-defined Ru-Ru double bonds.

Dalton transactions (Cambridge, England : 2003)·2026
Same author

Electron and spin density distributions and magnetic anisotropy in mixed-valent diruthenium(V) tetracarboxylates assessed <i>via</i> crystallographic and theoretical analyses.

Dalton transactions (Cambridge, England : 2003)·2026
Same author

Factors Affecting Intraoperative RBC Transfusion in Cerebrovascular Surgery.

Cureus·2026
Same author

Evaluation of peripheral blood stem cell collection in the Japan Marrow Donor Program (JMDP).

Transfusion·2025
Same author

Copper(II) and Dioxovanadium(V) Complexes Based on the Antiproliferative Chelating Agent HDpk44mT: Crystallographic Analyses, Spectroscopic Features, and Cytotoxicity.

ACS omega·2025
Same author

Paddlewheel-type and half-paddlewheel-type diruthenium(II,II) complexes with 1,8-naphthyridine-2-carboxylate.

Dalton transactions (Cambridge, England : 2003)·2025
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles